Bio-Path Holdings, Inc. Announces Pricing Of $2.1M Public Offering Of 3.5M Shares Of Common Stock And Warrant For A Purchase Price Of $0.60/Unit
Bio-Path Holdings, Inc., (NASDAQ:BPTH) ("Bio-Path" or the "Company"), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio of